FUBP1 Human (+)-schisandrin B multiple interactions ISO Fubp1 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of FUBP1 mRNA] CTD PMID:31150632 FUBP1 Human 1,2-dimethylhydrazine affects expression ISO Fubp1 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine affects the expression of FUBP1 mRNA CTD PMID:22206623 FUBP1 Human 17alpha-ethynylestradiol increases expression ISO Fubp1 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of FUBP1 mRNA CTD PMID:17942748 FUBP1 Human 17alpha-ethynylestradiol affects expression ISO Fubp1 (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of FUBP1 mRNA CTD PMID:17555576 FUBP1 Human 17alpha-ethynylestradiol multiple interactions ISO Fubp1 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FUBP1 mRNA CTD PMID:17942748 FUBP1 Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Fubp1 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FUBP1 mRNA and Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to FUBP1 promoter] CTD PMID:17942748 and PMID:19654925 FUBP1 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Fubp1 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of FUBP1 mRNA CTD PMID:33387578 FUBP1 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Fubp1 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of FUBP1 mRNA CTD PMID:34747641 FUBP1 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Fubp1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of FUBP1 mRNA CTD PMID:21570461 FUBP1 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Fubp1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of FUBP1 mRNA CTD PMID:17942748 and PMID:28922406 FUBP1 Human 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression ISO Fubp1 (Rattus norvegicus) 6480464 2 more ... CTD PMID:19954255 FUBP1 Human 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO Fubp1 (Rattus norvegicus) 6480464 2 more ... CTD PMID:19954255 FUBP1 Human 2,4-dinitrotoluene affects expression ISO Fubp1 (Rattus norvegicus) 6480464 2 and 4-dinitrotoluene affects the expression of FUBP1 mRNA CTD PMID:21346803 FUBP1 Human 2-hydroxypropanoic acid increases expression EXP 6480464 Lactic Acid results in increased expression of FUBP1 mRNA CTD PMID:30851411 FUBP1 Human 3,4-methylenedioxymethamphetamine increases expression ISO Fubp1 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of FUBP1 mRNA CTD PMID:20188158 FUBP1 Human 3,4-methylenedioxymethamphetamine decreases expression ISO Fubp1 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of FUBP1 mRNA CTD PMID:26251327 FUBP1 Human 3-chloropropane-1,2-diol increases expression ISO Fubp1 (Rattus norvegicus) 6480464 alpha-Chlorohydrin results in increased expression of FUBP1 protein CTD PMID:34915118 FUBP1 Human 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of FUBP1 mRNA CTD PMID:28628672 FUBP1 Human 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of FUBP1 mRNA CTD PMID:28628672 FUBP1 Human 4,4'-sulfonyldiphenol increases expression EXP 6480464 bisphenol S results in increased expression of FUBP1 protein CTD PMID:34186270 FUBP1 Human 4-hydroxynon-2-enal decreases expression EXP 6480464 4-hydroxy-2-nonenal results in decreased expression of FUBP1 mRNA CTD PMID:12419474 FUBP1 Human 4-hydroxyphenyl retinamide increases expression ISO Fubp1 (Mus musculus) 6480464 Fenretinide results in increased expression of FUBP1 mRNA CTD PMID:28973697 FUBP1 Human acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of FUBP1 mRNA CTD PMID:32763439 FUBP1 Human aflatoxin B1 increases expression ISO Fubp1 (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of FUBP1 mRNA CTD PMID:19770486 FUBP1 Human all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of FUBP1 mRNA CTD PMID:16054129 FUBP1 Human amphetamine decreases expression ISO Fubp1 (Rattus norvegicus) 6480464 Amphetamine results in decreased expression of FUBP1 mRNA CTD PMID:30779732 FUBP1 Human amphotericin B decreases expression EXP 6480464 Amphotericin B analog results in decreased expression of FUBP1 mRNA CTD PMID:28534445 FUBP1 Human aristolochic acid A decreases expression EXP 6480464 aristolochic acid I results in decreased expression of FUBP1 mRNA CTD PMID:33212167 FUBP1 Human Aroclor 1254 decreases expression ISO Fubp1 (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of FUBP1 mRNA CTD PMID:23650126 FUBP1 Human arsane affects methylation EXP 6480464 Arsenic affects the methylation of FUBP1 gene CTD PMID:25304211 FUBP1 Human arsenic atom affects methylation EXP 6480464 Arsenic affects the methylation of FUBP1 gene CTD PMID:25304211 FUBP1 Human arsenite(3-) increases methylation EXP 6480464 arsenite results in increased methylation of FUBP1 promoter CTD PMID:23974009 FUBP1 Human arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of FUBP1 protein CTD PMID:19364129 and PMID:25419056 FUBP1 Human arsenous acid increases response to substance EXP 6480464 FUBP1 protein results in increased susceptibility to Arsenic Trioxide CTD PMID:20707922 FUBP1 Human benzo[a]pyrene diol epoxide I decreases expression EXP 6480464 7 more ... CTD PMID:20018196 FUBP1 Human bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FUBP1 mRNA CTD PMID:20678512 and PMID:29275510 FUBP1 Human bisphenol A decreases expression ISO Fubp1 (Mus musculus) 6480464 bisphenol A results in decreased expression of FUBP1 mRNA CTD PMID:32156529 more ... FUBP1 Human bisphenol A affects methylation ISO Fubp1 (Mus musculus) 6480464 bisphenol A affects the methylation of FUBP1 promoter CTD PMID:27334623 FUBP1 Human bisphenol A increases methylation ISO Fubp1 (Mus musculus) 6480464 bisphenol A results in increased methylation of FUBP1 promoter CTD PMID:27312807 FUBP1 Human bisphenol A decreases expression ISO Fubp1 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of FUBP1 mRNA and bisphenol A results in decreased expression of FUBP1 protein CTD PMID:30816183 more ... FUBP1 Human bisphenol A affects expression ISO Fubp1 (Rattus norvegicus) 6480464 bisphenol A affects the expression of FUBP1 mRNA CTD PMID:25181051 and PMID:32145629 FUBP1 Human bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of FUBP1 protein CTD PMID:34186270 FUBP1 Human bleomycin A2 increases expression ISO Fubp1 (Rattus norvegicus) 6480464 Bleomycin results in increased expression of FUBP1 protein CTD PMID:25933445 FUBP1 Human butyric acid increases expression EXP 6480464 Butyric Acid results in increased expression of FUBP1 protein CTD PMID:34581912 FUBP1 Human cadmium atom multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FUBP1 mRNA CTD PMID:35301059 FUBP1 Human cadmium dichloride multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FUBP1 mRNA CTD PMID:35301059 FUBP1 Human caffeine affects phosphorylation EXP 6480464 Caffeine affects the phosphorylation of FUBP1 protein CTD PMID:35688186 FUBP1 Human carbamazepine affects expression EXP 6480464 Carbamazepine affects the expression of FUBP1 mRNA CTD PMID:25979313 FUBP1 Human carbon nanotube increases expression ISO Fubp1 (Mus musculus) 6480464 Nanotubes and Carbon results in increased expression of FUBP1 mRNA CTD PMID:25554681 FUBP1 Human CGP 52608 multiple interactions EXP 6480464 CGP 52608 promotes the reaction [RORA protein binds to FUBP1 gene] CTD PMID:28238834 FUBP1 Human choline multiple interactions ISO Fubp1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of FUBP1 mRNA CTD PMID:20938992 FUBP1 Human cisplatin decreases expression ISO Fubp1 (Mus musculus) 6480464 Cisplatin results in decreased expression of FUBP1 mRNA CTD PMID:21151649 FUBP1 Human cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of FUBP1 mRNA CTD PMID:27392435 FUBP1 Human cisplatin multiple interactions ISO Fubp1 (Mus musculus) 6480464 [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of FUBP1 mRNA CTD PMID:23625948 FUBP1 Human clofibrate increases expression ISO Fubp1 (Mus musculus) 6480464 Clofibrate results in increased expression of FUBP1 mRNA CTD PMID:17585979 FUBP1 Human clozapine increases expression EXP 6480464 Clozapine results in increased expression of FUBP1 protein CTD PMID:34122009 FUBP1 Human cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of FUBP1 mRNA CTD PMID:19320972 FUBP1 Human cocaine affects expression ISO Fubp1 (Rattus norvegicus) 6480464 Cocaine affects the expression of FUBP1 mRNA CTD PMID:20187946 FUBP1 Human copper(II) chloride increases expression ISO Fubp1 (Mus musculus) 6480464 cupric chloride results in increased expression of FUBP1 protein CTD PMID:29617964 FUBP1 Human cordycepin increases expression ISO Fubp1 (Mus musculus) 6480464 cordycepin results in increased expression of FUBP1 mRNA CTD PMID:32042022 FUBP1 Human coumarin increases phosphorylation EXP 6480464 coumarin results in increased phosphorylation of FUBP1 protein CTD PMID:35688186 FUBP1 Human cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of FUBP1 mRNA CTD PMID:25562108 FUBP1 Human dexamethasone multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of FUBP1 mRNA CTD PMID:28628672 FUBP1 Human diallyl trisulfide increases expression EXP 6480464 diallyl trisulfide results in increased expression of FUBP1 protein CTD PMID:16344271 FUBP1 Human diarsenic trioxide increases response to substance EXP 6480464 FUBP1 protein results in increased susceptibility to Arsenic Trioxide CTD PMID:20707922 FUBP1 Human diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of FUBP1 protein CTD PMID:19364129 and PMID:25419056 FUBP1 Human dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 FUBP1 Human doxorubicin decreases response to substance EXP 6480464 FUBP1 protein results in decreased susceptibility to Doxorubicin CTD PMID:24675091 FUBP1 Human doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of FUBP1 mRNA CTD PMID:29803840 FUBP1 Human doxorubicin affects expression EXP 6480464 Doxorubicin affects the expression of FUBP1 protein CTD PMID:29385562 FUBP1 Human enzyme inhibitor multiple interactions EXP 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of FUBP1 protein CTD PMID:23301498 FUBP1 Human finasteride increases expression ISO Fubp1 (Rattus norvegicus) 6480464 Finasteride results in increased expression of FUBP1 mRNA CTD PMID:24136188 FUBP1 Human flutamide increases expression ISO Fubp1 (Rattus norvegicus) 6480464 Flutamide results in increased expression of FUBP1 mRNA CTD PMID:24136188 FUBP1 Human folic acid multiple interactions ISO Fubp1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of FUBP1 mRNA CTD PMID:20938992 FUBP1 Human FR900359 increases phosphorylation EXP 6480464 FR900359 results in increased phosphorylation of FUBP1 protein CTD PMID:37730182 FUBP1 Human gentamycin increases expression ISO Fubp1 (Rattus norvegicus) 6480464 Gentamicins results in increased expression of FUBP1 mRNA CTD PMID:33387578 FUBP1 Human geraniol decreases expression EXP 6480464 geraniol results in decreased expression of FUBP1 mRNA CTD PMID:27683099 FUBP1 Human hexadecanoic acid decreases phosphorylation EXP 6480464 Palmitic Acid results in decreased phosphorylation of FUBP1 protein CTD PMID:28073184 FUBP1 Human hyaluronic acid multiple interactions ISO Fubp1 (Rattus norvegicus) 6480464 [Hyaluronic Acid analog co-treated with Hydrogen Peroxide] results in increased expression of FUBP1 protein CTD PMID:23178681 FUBP1 Human hyaluronic acid affects expression ISO Fubp1 (Rattus norvegicus) 6480464 Hyaluronic Acid analog affects the expression of FUBP1 protein CTD PMID:23178681 FUBP1 Human hydrogen peroxide multiple interactions ISO Fubp1 (Rattus norvegicus) 6480464 [Hyaluronic Acid analog co-treated with Hydrogen Peroxide] results in increased expression of FUBP1 protein CTD PMID:23178681 FUBP1 Human indometacin multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of FUBP1 mRNA CTD PMID:28628672 FUBP1 Human ivermectin decreases expression EXP 6480464 Ivermectin results in decreased expression of FUBP1 protein CTD PMID:32959892 FUBP1 Human ketamine decreases expression ISO Fubp1 (Rattus norvegicus) 6480464 Ketamine results in decreased expression of FUBP1 mRNA CTD PMID:20080153 FUBP1 Human L-methionine multiple interactions ISO Fubp1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of FUBP1 mRNA CTD PMID:20938992 FUBP1 Human lead(0) affects expression EXP 6480464 Lead affects the expression of FUBP1 mRNA CTD PMID:28903495 FUBP1 Human leflunomide decreases expression EXP 6480464 leflunomide results in decreased expression of FUBP1 mRNA CTD PMID:28988120 FUBP1 Human lipopolysaccharide multiple interactions EXP 6480464 [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of FUBP1 mRNA CTD PMID:35877022 FUBP1 Human methoxychlor affects methylation ISO Fubp1 (Rattus norvegicus) 6480464 Methoxychlor affects the methylation of FUBP1 gene CTD PMID:35440735 FUBP1 Human miconazole decreases expression ISO Fubp1 (Mus musculus) 6480464 Miconazole results in decreased expression of FUBP1 mRNA CTD PMID:27462272 FUBP1 Human N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of FUBP1 protein CTD PMID:24675778 FUBP1 Human N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of FUBP1 mRNA CTD PMID:24810058 FUBP1 Human nickel atom decreases expression EXP 6480464 Nickel results in decreased expression of FUBP1 mRNA CTD PMID:24768652 FUBP1 Human ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of FUBP1 protein CTD PMID:26861962 FUBP1 Human oxaliplatin multiple interactions ISO Fubp1 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of FUBP1 mRNA CTD PMID:25729387 FUBP1 Human paracetamol affects expression ISO Fubp1 (Mus musculus) 6480464 Acetaminophen affects the expression of FUBP1 mRNA CTD PMID:17562736 FUBP1 Human paracetamol decreases expression ISO Fubp1 (Rattus norvegicus) 6480464 Acetaminophen results in decreased expression of FUBP1 mRNA CTD PMID:33387578 FUBP1 Human paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of FUBP1 mRNA CTD PMID:21420995 FUBP1 Human pentachlorophenol increases expression ISO Fubp1 (Mus musculus) 6480464 Pentachlorophenol results in increased expression of FUBP1 mRNA CTD PMID:23892564 FUBP1 Human phenobarbital decreases expression ISO Fubp1 (Mus musculus) 6480464 Phenobarbital results in decreased expression of FUBP1 mRNA CTD PMID:23091169 FUBP1 Human phenylmercury acetate decreases expression EXP 6480464 Phenylmercuric Acetate results in decreased expression of FUBP1 mRNA CTD PMID:26272509 FUBP1 Human phenylmercury acetate multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FUBP1 mRNA CTD PMID:27188386 FUBP1 Human pirinixic acid decreases expression ISO Fubp1 (Mus musculus) 6480464 pirinixic acid results in decreased expression of FUBP1 mRNA CTD PMID:18445702 FUBP1 Human quinoline decreases expression EXP 6480464 quinoline analog results in decreased expression of FUBP1 protein CTD PMID:18645022 FUBP1 Human rac-lactic acid increases expression EXP 6480464 Lactic Acid results in increased expression of FUBP1 mRNA CTD PMID:30851411 FUBP1 Human resveratrol multiple interactions EXP 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of FUBP1 mRNA CTD PMID:23557933 FUBP1 Human SB 431542 multiple interactions EXP 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 and PMID:37664457 FUBP1 Human silicon dioxide decreases expression ISO Fubp1 (Mus musculus) 6480464 Silicon Dioxide results in decreased expression of FUBP1 mRNA CTD PMID:19073995 FUBP1 Human sodium arsenate increases expression ISO Fubp1 (Mus musculus) 6480464 sodium arsenate results in increased expression of FUBP1 mRNA CTD PMID:21795629 FUBP1 Human sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of FUBP1 protein CTD PMID:20050688 FUBP1 Human sodium dichromate affects expression ISO Fubp1 (Rattus norvegicus) 6480464 sodium bichromate affects the expression of FUBP1 mRNA CTD PMID:22110744 FUBP1 Human sodium dichromate increases expression ISO Fubp1 (Rattus norvegicus) 6480464 sodium bichromate results in increased expression of FUBP1 mRNA CTD PMID:25993096 FUBP1 Human succimer multiple interactions ISO Fubp1 (Mus musculus) 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FUBP1 mRNA CTD PMID:21641980 FUBP1 Human sunitinib decreases expression EXP 6480464 Sunitinib results in decreased expression of FUBP1 mRNA CTD PMID:31533062 FUBP1 Human T-2 toxin affects expression ISO Fubp1 (Rattus norvegicus) 6480464 T-2 Toxin affects the expression of FUBP1 protein CTD PMID:26141394 FUBP1 Human tamoxifen affects expression ISO Fubp1 (Mus musculus) 6480464 Tamoxifen affects the expression of FUBP1 mRNA CTD PMID:17555576 FUBP1 Human tanespimycin multiple interactions EXP 6480464 [tanespimycin co-treated with VER 155008] results in increased expression of FUBP1 protein CTD PMID:31370342 FUBP1 Human tert-butyl hydroperoxide increases expression EXP 6480464 tert-Butylhydroperoxide results in increased expression of FUBP1 mRNA CTD PMID:15336504 FUBP1 Human tetrachloromethane increases expression ISO Fubp1 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of FUBP1 mRNA CTD PMID:27339419 and PMID:31919559 FUBP1 Human tetrachloromethane increases expression ISO Fubp1 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in increased expression of FUBP1 mRNA CTD PMID:31150632 FUBP1 Human tetrachloromethane multiple interactions ISO Fubp1 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of FUBP1 mRNA] CTD PMID:31150632 FUBP1 Human thapsigargin decreases expression ISO Fubp1 (Rattus norvegicus) 6480464 Thapsigargin results in decreased expression of FUBP1 protein CTD PMID:35544339 FUBP1 Human thioacetamide increases expression ISO Fubp1 (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of FUBP1 mRNA CTD PMID:23411599 and PMID:34492290 FUBP1 Human topotecan multiple interactions ISO Fubp1 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of FUBP1 mRNA CTD PMID:25729387 FUBP1 Human trichloroethene decreases expression ISO Fubp1 (Rattus norvegicus) 6480464 Trichloroethylene results in decreased expression of FUBP1 mRNA CTD PMID:33387578 FUBP1 Human trichostatin A decreases expression EXP 6480464 trichostatin A results in decreased expression of FUBP1 mRNA CTD PMID:26272509 FUBP1 Human trichostatin A multiple interactions EXP 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FUBP1 mRNA CTD PMID:27188386 FUBP1 Human Triptolide increases expression ISO Fubp1 (Mus musculus) 6480464 triptolide results in increased expression of FUBP1 mRNA CTD PMID:32835833 FUBP1 Human triptonide increases expression ISO Fubp1 (Mus musculus) 6480464 triptonide results in increased expression of FUBP1 mRNA CTD PMID:33045310 FUBP1 Human troglitazone decreases expression ISO Fubp1 (Mus musculus) 6480464 troglitazone results in decreased expression of FUBP1 mRNA CTD PMID:28973697 FUBP1 Human trovafloxacin increases expression ISO Fubp1 (Mus musculus) 6480464 trovafloxacin results in increased expression of FUBP1 mRNA CTD PMID:35537566 FUBP1 Human valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of FUBP1 mRNA CTD PMID:25979313 FUBP1 Human valproic acid multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FUBP1 mRNA CTD PMID:27188386 FUBP1 Human valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of FUBP1 mRNA CTD PMID:23179753 more ... FUBP1 Human vinclozolin affects expression ISO Fubp1 (Rattus norvegicus) 6480464 vinclozolin affects the expression of FUBP1 mRNA CTD PMID:19015723 FUBP1 Human vincristine decreases expression EXP 6480464 Vincristine results in decreased expression of FUBP1 mRNA CTD PMID:23649840
